171 related articles for article (PubMed ID: 6391491)
1. 6-Keto-prostaglandin E1-sensitive adenylate cyclase and binding sites in membranes from platelets and cultured smooth muscle cells.
Oliva D; Bernini F; Corsini A; Nicosia S
Biochem Pharmacol; 1984 Dec; 33(23):3755-8. PubMed ID: 6391491
[TBL] [Abstract][Full Text] [Related]
2. (5Z)-carbacyclin discriminates between prostacyclin-receptors coupled to adenylate cyclase in vascular smooth muscle and platelets.
Corsini A; Folco GC; Fumagalli R; Nicosia S; Noe MA; Oliva D
Br J Pharmacol; 1987 Jan; 90(1):255-61. PubMed ID: 3545351
[TBL] [Abstract][Full Text] [Related]
3. Prostacyclin-sensitive adenylate cyclase in cultured myocytes: differences between rabbit aorta and mesenteric artery.
Oliva D; Noè A; Nicosia S; Bernini F; Fumagalli R; Whittle BJ; Moncada S; Vane JR
Eur J Pharmacol; 1984 Oct; 105(3-4):207-13. PubMed ID: 6391937
[TBL] [Abstract][Full Text] [Related]
4. (5Z)-carbacyclin displays agonist-antagonist properties on prostacyclin-receptors in platelets and vascular myocytes.
Corsini A; Oliva D; Folco GC; Giovanazzi S; Noe' MA; Fumagalli R; Nicosia S
Biomed Biochim Acta; 1988; 47(10-11):S104-7. PubMed ID: 3073757
[TBL] [Abstract][Full Text] [Related]
5. The use of stable prostaglandins to investigate prostacyclin (PGI2)-binding sites and PGI2-sensitive adenylate cyclase in human platelet membranes.
Lombroso M; Nicosia S; Paoletti R; Whittle BJ; Moncada S; Vane JR
Prostaglandins; 1984 Feb; 27(2):321-33. PubMed ID: 6326201
[TBL] [Abstract][Full Text] [Related]
6. Interrelationships between PGE1 and PGI2 binding and stimulation of adenylate cyclase.
Garrity MJ; Westcott KR; Eggerman TL; Andersen NH; Storm DR; Robertson RP
Am J Physiol; 1983 Apr; 244(4):E367-72. PubMed ID: 6132556
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the effects of prostacyclin and 6-keto-prostaglandin E1 on renin release in the isolated rat and rabbit kidney.
Schwertschlag U; Stahl T; Hackenthal E
Prostaglandins; 1982 Jan; 23(1):129-38. PubMed ID: 7038776
[TBL] [Abstract][Full Text] [Related]
8. 6-keto-prostaglandin E1 is not equipotent to prostacyclin (PGI2) as an antiaggregatory agent.
Miller OV; Aiken JW; Shebuski RJ; Gorman RR
Prostaglandins; 1980 Aug; 20(2):391-400. PubMed ID: 6251513
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of in vitro ethanol on prostaglandin E1-sensitive adenylate cyclase from smooth muscle cells and platelets.
Noe M; Oliva D; Corsini A; Soma M; Fumagalli R; Nicosia S
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(4):293-308. PubMed ID: 4040929
[TBL] [Abstract][Full Text] [Related]
10. Conversion of prostacyclin to 6 oxo prostaglandin E1 by rat, rabbit, guinea-pig and human platelets.
Griffiths RJ; Moore PK
Br J Pharmacol; 1983 Oct; 80(2):395-402. PubMed ID: 6360281
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E1 action on adenylate cyclase activity and membrane lipids in platelets.
Mruk J; Bakardjiev A; Burgermeister W
Hoppe Seylers Z Physiol Chem; 1982 Jul; 363(7):745-56. PubMed ID: 6957369
[TBL] [Abstract][Full Text] [Related]
12. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
[TBL] [Abstract][Full Text] [Related]
13. Prostacyclin-sensitive adenylate cyclase and prostacyclin binding sites in platelets and smooth muscle cells.
Nicosia S; Oliva D; Bernini F; Fumagalli R
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():593-9. PubMed ID: 6328938
[No Abstract] [Full Text] [Related]
14. 6-Keto-prostaglandin E1: its formation by platelets from prostacyclin and resistance to pulmonary degradation.
Berry CN; Hoult JR
Pharmacology; 1983; 26(6):324-30. PubMed ID: 6348806
[TBL] [Abstract][Full Text] [Related]
15. Adenylate cyclase-mediated vascular responses of rabbit aorta, mesenteric artery and skin microcirculation.
Wilson AJ; Warren JB
Br J Pharmacol; 1993 Oct; 110(2):633-8. PubMed ID: 7902177
[TBL] [Abstract][Full Text] [Related]
16. The effect of carbacyclin, a prostaglandin analogue, on adenylate cyclase activity in platelet membranes.
Stein JM; Martin BR
FEBS Lett; 1984 Jan; 165(2):290-2. PubMed ID: 6363123
[TBL] [Abstract][Full Text] [Related]
17. The binding of 6-oxo-prostaglandin E1 to platelet prostanoid receptors.
Jaschonek K; Renn W; Weisenberger H
Prostaglandins Leukot Med; 1986 Sep; 24(1):79-86. PubMed ID: 3020591
[TBL] [Abstract][Full Text] [Related]
18. 6-Keto-prostaglandin E1 is a potent coronary vasodilator and stimulates a vagal reflex in dogs.
Panzenbeck MJ; Hintze TH; Kaley G
J Pharmacol Exp Ther; 1988 Mar; 244(3):814-9. PubMed ID: 3075239
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of prostacyclin by 9-hydroxyprostaglandin dehydrogenase in human platelets. Formation of a potent inhibitor of platelet aggregation and enzyme purification.
Wong PY; Lee WH; Chao PH; Reiss RF; McGiff JC
J Biol Chem; 1980 Oct; 255(19):9021-4. PubMed ID: 6997309
[TBL] [Abstract][Full Text] [Related]
20. 6-Keto-prostaglandin E1 is more potent than prostaglandin I2 as a renal vasodilator and renin secretagogue.
Jackson EK; Herzer WA; Zimmerman JB; Branch RA; Oates JA; Gerkens JF
J Pharmacol Exp Ther; 1981 Jan; 216(1):24-7. PubMed ID: 7005428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
